CD44 and breast carcinoma: Because CIN in breast cancer is mechanistically linked to development of centrosome abnormalities, we analyzed the grade of centrosome amplification in bulk SUM149PT cancer cells versus the stem-like CD44+/CD24−/Low subpopulation isolated by FACS sorting assay.